amino acid derivatives Search Results


actinomycin d  (Toronto Research Chemicals)
86
Toronto Research Chemicals actinomycin d
Actinomycin D, supplied by Toronto Research Chemicals, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/amino+acid+derivatives/Actinomycin+D/10__1016_slash_j__jff__2020__103842-34-0-7
Average 86 stars, based on 1 article reviews
actinomycin d - by Bioz Stars, 2026-10
86/100 stars
  Buy from Supplier
l j vi o n  (MedChemExpress)
94
MedChemExpress l j vi o n
L J Vi O N, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/amino+acid+derivatives/A11/pm41910405-332-30-83
Average 94 stars, based on 1 article reviews
l j vi o n - by Bioz Stars, 2026-10
94/100 stars
  Buy from Supplier
phenylalanine d5  (Toronto Research Chemicals)
91
Toronto Research Chemicals phenylalanine d5
Phenylalanine D5, supplied by Toronto Research Chemicals, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/amino+acid+derivatives/Lysipressin-d5+Trifluoroacetic+Acid+Salt/pmc09967652-77-14-22
Average 91 stars, based on 1 article reviews
phenylalanine d5 - by Bioz Stars, 2026-10
91/100 stars
  Buy from Supplier
fmoc l lys boc oh  (Chem Impex International)
95
Chem Impex International fmoc l lys boc oh
Fmoc L Lys Boc Oh, supplied by Chem Impex International, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/amino+acid+derivatives/Na-Fmoc-Ne-Boc-L-lysine/pmc05856623-6-14-33
Average 95 stars, based on 1 article reviews
fmoc l lys boc oh - by Bioz Stars, 2026-10
95/100 stars
  Buy from Supplier
cephalomannine ceph  (ChromaDex)
88
ChromaDex cephalomannine ceph
Cephalomannine Ceph, supplied by ChromaDex, used in various techniques. Bioz Stars score: 88/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/amino+acid+derivatives/Cephalomannine/pmc05865277-63-17-24
Average 88 stars, based on 1 article reviews
cephalomannine ceph - by Bioz Stars, 2026-10
88/100 stars
  Buy from Supplier
na fmoc n im trityl l histidine  (Chem Impex International)
95
Chem Impex International na fmoc n im trityl l histidine
Na Fmoc N Im Trityl L Histidine, supplied by Chem Impex International, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/amino+acid+derivatives/L-Histidine/10__1039_slash_c8ra00315g-371-0-9
Average 95 stars, based on 1 article reviews
na fmoc n im trityl l histidine - by Bioz Stars, 2026-10
95/100 stars
  Buy from Supplier
paclitaxel  (Chem Impex International)
95
Chem Impex International paclitaxel
Chemotherapeutic synergy. (a) Isobolograms of MAD1 and Doxorubicin (Dox), <t>Paclitaxel</t> (Ptx) or Cisplatin (Cis) combinatorial synergy in OVCAR-3 (left) and NCI/ADR-RES (right) cells. Fractional inhibitory concentration (FIC) < 1 and < 0.5 represent additive and synergistic effects, respectively. (b) Comparison of Dox and Cis IC50 towards NCI/ADR-RES as either a monotherapy (ADR-RES, black) or in combination with 20 μM MAD1 (ADR-RES + MAD1, grey). Activity of each drug as a monotherapy in pre-resistant OVCAR-3 (OVCAR-3, white) cells shown for comparison. (c–f) Indicated ovarian cancer cell line or patient-derived ovarian carcinoma cells were cultured in ultra-low attachment conditions and treated for 48 h with 2 μM cisplatin or 4 μM MAD1 alone and in combination. Data represent volume in arbitrary units (a.u.) and median.
Paclitaxel, supplied by Chem Impex International, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/amino+acid+derivatives/Paclitaxel/pmc07596148-84-17-21
Average 95 stars, based on 1 article reviews
paclitaxel - by Bioz Stars, 2026-10
95/100 stars
  Buy from Supplier
carboxyphenol ba  (Chem Impex International)
95
Chem Impex International carboxyphenol ba
Chemotherapeutic synergy. (a) Isobolograms of MAD1 and Doxorubicin (Dox), <t>Paclitaxel</t> (Ptx) or Cisplatin (Cis) combinatorial synergy in OVCAR-3 (left) and NCI/ADR-RES (right) cells. Fractional inhibitory concentration (FIC) < 1 and < 0.5 represent additive and synergistic effects, respectively. (b) Comparison of Dox and Cis IC50 towards NCI/ADR-RES as either a monotherapy (ADR-RES, black) or in combination with 20 μM MAD1 (ADR-RES + MAD1, grey). Activity of each drug as a monotherapy in pre-resistant OVCAR-3 (OVCAR-3, white) cells shown for comparison. (c–f) Indicated ovarian cancer cell line or patient-derived ovarian carcinoma cells were cultured in ultra-low attachment conditions and treated for 48 h with 2 μM cisplatin or 4 μM MAD1 alone and in combination. Data represent volume in arbitrary units (a.u.) and median.
Carboxyphenol Ba, supplied by Chem Impex International, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/amino+acid+derivatives/Salicylic+acid/pm33543929-33-0-5
Average 95 stars, based on 1 article reviews
carboxyphenol ba - by Bioz Stars, 2026-10
95/100 stars
  Buy from Supplier
docetaxel dtx  (ChromaDex)
90
ChromaDex docetaxel dtx
Chemotherapeutic synergy. (a) Isobolograms of MAD1 and Doxorubicin (Dox), <t>Paclitaxel</t> (Ptx) or Cisplatin (Cis) combinatorial synergy in OVCAR-3 (left) and NCI/ADR-RES (right) cells. Fractional inhibitory concentration (FIC) < 1 and < 0.5 represent additive and synergistic effects, respectively. (b) Comparison of Dox and Cis IC50 towards NCI/ADR-RES as either a monotherapy (ADR-RES, black) or in combination with 20 μM MAD1 (ADR-RES + MAD1, grey). Activity of each drug as a monotherapy in pre-resistant OVCAR-3 (OVCAR-3, white) cells shown for comparison. (c–f) Indicated ovarian cancer cell line or patient-derived ovarian carcinoma cells were cultured in ultra-low attachment conditions and treated for 48 h with 2 μM cisplatin or 4 μM MAD1 alone and in combination. Data represent volume in arbitrary units (a.u.) and median.
Docetaxel Dtx, supplied by ChromaDex, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/amino+acid+derivatives/Docetaxel/10__1039_slash_c5ra00803d-44-0-12
Average 90 stars, based on 1 article reviews
docetaxel dtx - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier
glycodeoxycholic acid  (Chem Impex International)
96
Chem Impex International glycodeoxycholic acid
Chemotherapeutic synergy. (a) Isobolograms of MAD1 and Doxorubicin (Dox), <t>Paclitaxel</t> (Ptx) or Cisplatin (Cis) combinatorial synergy in OVCAR-3 (left) and NCI/ADR-RES (right) cells. Fractional inhibitory concentration (FIC) < 1 and < 0.5 represent additive and synergistic effects, respectively. (b) Comparison of Dox and Cis IC50 towards NCI/ADR-RES as either a monotherapy (ADR-RES, black) or in combination with 20 μM MAD1 (ADR-RES + MAD1, grey). Activity of each drug as a monotherapy in pre-resistant OVCAR-3 (OVCAR-3, white) cells shown for comparison. (c–f) Indicated ovarian cancer cell line or patient-derived ovarian carcinoma cells were cultured in ultra-low attachment conditions and treated for 48 h with 2 μM cisplatin or 4 μM MAD1 alone and in combination. Data represent volume in arbitrary units (a.u.) and median.
Glycodeoxycholic Acid, supplied by Chem Impex International, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/amino+acid+derivatives/Glycodeoxycholic+acid/pm41386220-940-207-211
Average 96 stars, based on 1 article reviews
glycodeoxycholic acid - by Bioz Stars, 2026-10
96/100 stars
  Buy from Supplier
2 benzyloxycarbonylamino 6 tert butoxycarbonylamino hexanoic acid cbz lys boc oh  (Chem Impex International)
95
Chem Impex International 2 benzyloxycarbonylamino 6 tert butoxycarbonylamino hexanoic acid cbz lys boc oh
Chemotherapeutic synergy. (a) Isobolograms of MAD1 and Doxorubicin (Dox), <t>Paclitaxel</t> (Ptx) or Cisplatin (Cis) combinatorial synergy in OVCAR-3 (left) and NCI/ADR-RES (right) cells. Fractional inhibitory concentration (FIC) < 1 and < 0.5 represent additive and synergistic effects, respectively. (b) Comparison of Dox and Cis IC50 towards NCI/ADR-RES as either a monotherapy (ADR-RES, black) or in combination with 20 μM MAD1 (ADR-RES + MAD1, grey). Activity of each drug as a monotherapy in pre-resistant OVCAR-3 (OVCAR-3, white) cells shown for comparison. (c–f) Indicated ovarian cancer cell line or patient-derived ovarian carcinoma cells were cultured in ultra-low attachment conditions and treated for 48 h with 2 μM cisplatin or 4 μM MAD1 alone and in combination. Data represent volume in arbitrary units (a.u.) and median.
2 Benzyloxycarbonylamino 6 Tert Butoxycarbonylamino Hexanoic Acid Cbz Lys Boc Oh, supplied by Chem Impex International, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/amino+acid+derivatives/Na-Z-Ne-Boc-L-lysine/us08173800-750-12-15
Average 95 stars, based on 1 article reviews
2 benzyloxycarbonylamino 6 tert butoxycarbonylamino hexanoic acid cbz lys boc oh - by Bioz Stars, 2026-10
95/100 stars
  Buy from Supplier
tfa salt of the peptido amino acid derivative  (Peptido GmbH)
90
Peptido GmbH tfa salt of the peptido amino acid derivative
Chemotherapeutic synergy. (a) Isobolograms of MAD1 and Doxorubicin (Dox), <t>Paclitaxel</t> (Ptx) or Cisplatin (Cis) combinatorial synergy in OVCAR-3 (left) and NCI/ADR-RES (right) cells. Fractional inhibitory concentration (FIC) < 1 and < 0.5 represent additive and synergistic effects, respectively. (b) Comparison of Dox and Cis IC50 towards NCI/ADR-RES as either a monotherapy (ADR-RES, black) or in combination with 20 μM MAD1 (ADR-RES + MAD1, grey). Activity of each drug as a monotherapy in pre-resistant OVCAR-3 (OVCAR-3, white) cells shown for comparison. (c–f) Indicated ovarian cancer cell line or patient-derived ovarian carcinoma cells were cultured in ultra-low attachment conditions and treated for 48 h with 2 μM cisplatin or 4 μM MAD1 alone and in combination. Data represent volume in arbitrary units (a.u.) and median.
Tfa Salt Of The Peptido Amino Acid Derivative, supplied by Peptido GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/amino+acid+derivatives/tfa+salt+of+the+peptido+amino+acid+derivative/us08835602-747-13-12
Average 90 stars, based on 1 article reviews
tfa salt of the peptido amino acid derivative - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

Image Search Results


Chemotherapeutic synergy. (a) Isobolograms of MAD1 and Doxorubicin (Dox), Paclitaxel (Ptx) or Cisplatin (Cis) combinatorial synergy in OVCAR-3 (left) and NCI/ADR-RES (right) cells. Fractional inhibitory concentration (FIC) < 1 and < 0.5 represent additive and synergistic effects, respectively. (b) Comparison of Dox and Cis IC50 towards NCI/ADR-RES as either a monotherapy (ADR-RES, black) or in combination with 20 μM MAD1 (ADR-RES + MAD1, grey). Activity of each drug as a monotherapy in pre-resistant OVCAR-3 (OVCAR-3, white) cells shown for comparison. (c–f) Indicated ovarian cancer cell line or patient-derived ovarian carcinoma cells were cultured in ultra-low attachment conditions and treated for 48 h with 2 μM cisplatin or 4 μM MAD1 alone and in combination. Data represent volume in arbitrary units (a.u.) and median.

Journal: Cellular and Molecular Bioengineering

Article Title: Re-engineering Antimicrobial Peptides into Oncolytics Targeting Drug-Resistant Ovarian Cancers

doi: 10.1007/s12195-020-00626-z

Figure Lengend Snippet: Chemotherapeutic synergy. (a) Isobolograms of MAD1 and Doxorubicin (Dox), Paclitaxel (Ptx) or Cisplatin (Cis) combinatorial synergy in OVCAR-3 (left) and NCI/ADR-RES (right) cells. Fractional inhibitory concentration (FIC) < 1 and < 0.5 represent additive and synergistic effects, respectively. (b) Comparison of Dox and Cis IC50 towards NCI/ADR-RES as either a monotherapy (ADR-RES, black) or in combination with 20 μM MAD1 (ADR-RES + MAD1, grey). Activity of each drug as a monotherapy in pre-resistant OVCAR-3 (OVCAR-3, white) cells shown for comparison. (c–f) Indicated ovarian cancer cell line or patient-derived ovarian carcinoma cells were cultured in ultra-low attachment conditions and treated for 48 h with 2 μM cisplatin or 4 μM MAD1 alone and in combination. Data represent volume in arbitrary units (a.u.) and median.

Article Snippet: 3-(4,5-Dimethyl-2-thiazolyl)-2,5-diphenyl-2H-tetrazolium bromide (MTT), Fmoc-protected amino acids, N,N 0 -diisopropylcarbodiimide (DIC), O-(7-Azabenzotriazol-1-yl)-N,N,N’,N’-tetramethyluronium hexafluorophosphate (HATU), N,N -dimethylformamide (DMF), and Paclitaxel were purchased from Chem-Impex International, Inc. RPMI-1640, M199, trypsin and EDTA solution, Antibiotic-Antimycotic Solution, ultra-low attachment (ULA) plates, and 1× phosphate buffered saline (PBS) were purchased from Corning.

Techniques: Concentration Assay, Comparison, Activity Assay, Derivative Assay, Cell Culture